Research news

The Queen Square Clinical Trial Centre (QSCTC) has successfully delivered its first investigational medicinal product (IMP) treatment on John Young Ward at the National Hospital for Neurology and Neurosurgery.

UCLH has recruited the first participant in the UK for a study testing a new anti-cancer treatment combination for advanced solid tumours such as endometrial and ovarian cancers.

A team of clinicians and researchers at UCLH and UCL have been awarded a £2.8 million grant to combat health inequalities in patients having major surgery.

A quicker, cheaper MRI scan is just as accurate at diagnosing prostate cancer as the current 30-40 minute scan and should be rolled out to make MRI scans more accessible to men who need one, according to clinical trial results led by UCLH, UCL and the University of Birmingham.

A new treatment has been shown to significantly lower blood pressure in people whose levels stays dangerously high, despite taking several existing medicines, according to the results of a Phase III clinical trial led supported by the National Institute for Health and Care Research Biomedical Research Centre at UCLH.